FDA approve donanemab treatment for early Alzhiemer diseaseحلقة نقاشية

Name: FDA approve donanemab treatment for early Alzhiemer disease
Start: 2025-02-02T12:30:00+03:00
End: 2025-02-02T13:30:00+03:00
Location: كلية الصيدلة

Sunday 2 Feb 2025, 12:30 → 13:30 Asia/Baghdad

كلية الصيدلة